Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report)’s share price hit a new 52-week low on Saturday . The stock traded as low as $13.61 and last traded at $13.61, with a volume of 112377 shares trading hands. The stock had previously closed at $16.15.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on TLX. William Blair reaffirmed an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th. UBS Group raised their price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, January 27th.
Get Our Latest Stock Report on TLX
Telix Pharmaceuticals Limited American Depositary Shares Price Performance
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Read More
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- Why is the Ex-Dividend Date Significant to Investors?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How to Invest in Small Cap Stocks
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
